MIAMI—Positive rates for most sexually transmitted diseases are continuing to decline through January, according to Talent Testing Service’s (TTS) newest report.
The Chlamydia Urine Positivity Index showed that the three Chlamydia Urine rates demonstrate a steady downward trend from the November 2022 peak, although In January 2024 all rates have turned up from December 2023, having gone to 1.5 percent from 1.2 percent, previously. The male rate is at 1.7 percent from 1.6 percent and the female is at 1.4 percent from 0.7 percent. Altogether, January 2024 rates below 2.0 percent can be considered to be within expectations.
The Gonorrhea Urine Positivity Index shows decreases for the three rates with the female rate at 0.6 percent from 0.8 percent while the male rate went down to 0.2 percent from 0.5 percent with the total rate dropping to 0.4 percent from 0.6 percent. Looking at the trendline, the January 2024 levels can still be considered to be within regular levels.
The Trichomonas Vaginalis Urine Positivity Index showed an upturn for all three rates for January 2024, starting with the female rate to 1.1 percent from 0.1 percent with the total rate at 0.8 percent from 0.1 percent and the Male rate up to 0.5 percent from 0.0 percent. The current rate levels are within the general range of 0.0 to 1.5 percent.
Other highlights included:
• Mycoplasma Genitalium Urine Positivity Index – The downward direction started in August 2023 has stopped as all the January 2024 rates have increased, with the total rate increased to 6.9 percent from the December 2023 low of 6.1 percent, the female rate is at 7.6 percent from 6.4 percent while the male rate is at 6.0 from 5.9 percent. The rates continue to be monitored weekly.
• Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs Positivity Index – Based on market activity the positivity rates for the four tests have December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In January 2024, the rates show a further slight drop in the total rate going to 2.0 percent from 2.1 percent, while the male rate turned downward to 2.1 percent from 3.4 percent, and the Female rate now going up to 2.0 percent from 1.1 percent. The Chlamydia Throat rates continue to be aligned with their general trend with levels at or below 1.0 percent.
• Gonorrhea Rectal Rates – Although within an overall smaller range of 0.0 percent to 3.5 percent when compared to the other swab rates, the Gonorrhea rectal volatility since April 2023 continues with the male rate now up to 2.1 percent from 1.0 percent, the female rate decreasing to 0.3 percent from 1.3 percent and the total rate continuing to drop to 1.0 percent from 1.2 percent.
To read the full report, click here.
For more information, visit TalentTestingService.com.
